Medtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue?

Core Insights - Medtronic's shares have increased by approximately 5.6% since the last earnings report, outperforming the S&P 500 [1] - Recent estimates for Medtronic have trended downward over the past month [2] - The stock has an aggregate VGM Score of B, with a Growth Score of C and a Momentum Score of B [3] Earnings and Estimates - Estimates for Medtronic have broadly trended downward, indicating a downward shift in expectations [4] - Medtronic currently holds a Zacks Rank 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] Industry Performance - Medtronic is part of the Zacks Medical - Products industry, where another player, Haemonetics, has seen a 2.5% gain over the past month [5] - Haemonetics reported revenues of $348.54 million for the last quarter, reflecting a year-over-year increase of 3.7% [5] - Haemonetics is expected to post earnings of $1.22 per share for the current quarter, representing a year-over-year change of 35.6% [6]